GEODE CAPITAL MANAGEMENT, LLC

Position in ARVN — Arvinas, Inc.

CIK 1214717 BOSTON, MA

Back to ARVN Full portfolio

Position in ARVN

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$13,854,971

-$2,650,363 QoQ

Shares Held

1,667,265

+7.1% QoQ

Ownership

2.55%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

of 198 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARVN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $21,877,426,307 across 521 Biotechnology names. ARVN ranks #165 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,017,848	$2,989,245,636
2	REGN	Regeneron Pharmaceuticals, Inc.	2,625,810	$1,637,297,566
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,635,840	$793,466,914
4	RVMD	Revolution Medicines, Inc.	3,942,676	$738,384,360
5	MRNA	Moderna, Inc.	9,710,335	$680,014,759
6	INCY	Incyte Corp	4,750,735	$538,543,319
7	RPRX	Royalty Pharma plc	8,058,048	$451,814,751
8	INSM	INSMED Inc	4,220,155	$449,952,925

All Filings in ARVN

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,854,971	1,667,265	+7.1%	Shares	Defined	2026-08-12
2026-03-31	$16,505,334	1,557,107	-4.1%	Shares	Defined	2026-05-15
2025-12-31	$19,254,579	1,623,489	-2.8%	Shares	Defined	2026-02-09
2025-09-30	$14,229,925	1,670,179	+5.4%	Shares	Defined	2025-11-12
2025-06-30	$11,666,276	1,585,092	+3.1%	Shares	Defined	2025-08-08
2025-03-31	$10,788,307	1,536,796	+1.7%	Shares	Defined	2025-05-13
2024-12-31	$28,966,137	1,511,014	-0.5%	Shares	Defined	2025-02-12
2024-09-30	$37,421,196	1,519,334	-1.5%	Shares	Defined	2024-11-12
2024-06-30	$41,041,038	1,541,737	+17.4%	Shares	Defined	2024-08-09
2024-03-31	$54,213,684	1,313,316	+17.0%	Shares	Defined	2024-05-13
2023-12-31	$46,207,327	1,122,627	+6.2%	Shares	Defined	2024-02-13
2023-09-30	$20,767,139	1,057,390	+6.3%	Shares	Defined	2023-11-13
2023-06-30	$24,695,254	994,974	+4.1%	Shares	Defined	2023-08-11
2023-03-31	$26,112,483	955,801	+4.5%	Shares	Defined	2023-05-15
2022-12-31	$31,277,997	914,294	+3.4%	Shares	Defined	2023-02-13
2022-09-30	$39,334,721	884,125	+7.7%	Shares	Defined	2022-11-14
2022-06-30	$34,561,445	821,132	-0.5%	Shares	Defined	2022-08-12
2022-03-31	$55,548,747	825,390	+3.0%	Shares	Defined	2022-05-13
2021-12-31	$65,845,066	801,620	+5.2%	Shares	Defined	2022-02-11
2021-09-30	$62,631,761	762,129	+13.4%	Shares	Defined	2021-11-12
2021-06-30	$51,731,218	671,834	+13.1%	Shares	Defined	2021-08-13
2021-03-31	$39,261,549	593,972	+15.1%	Shares	Defined	2021-05-12
2020-12-31	$43,833,901	516,118	+31.8%	Shares	Defined	2021-02-12
2020-09-30	$9,246,927	391,653	+16.2%	Shares	Defined	2020-11-13
2020-06-30	$11,307,776	337,143	+21.4%	Shares	Defined	2020-08-13
2020-03-31	$11,196,387	277,826	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.